Biofunctional self-assembled nanoparticles of folate-PEG-heparin/PBLA copolymers for targeted delivery of doxorubicin

Journal of Materials Chemistry

Volumn 21, Issue 39, 2011, Pages 15288-15297

  Li, Li ^a   Huh, Kang Moo ^a   Lee, Yong Kyu ^b   Kim, So Yeon ^a  

^a Chungnam National University   (South Korea)

^b Chungju National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

A549 CELLS; ACTIVE TARGETING; AMPHIPHILIC COPOLYMERS; ANTICANCER DRUG; ANTICANCER PROPERTIES; AVERAGE DIAMETER; CYTOTOXIC EFFECTS; DIALYSIS METHOD; DOXORUBICIN; DRUG CARRIER; DRUG DELIVERY SYSTEM; DRUG LOADING; DRUG RELEASE; ENDOSOMES; HIGH LOADINGS; INTRACELLULAR UPTAKE; NANO PARTICULATES; PH VALUE; PH-DEPENDENT; RELEASE PROPERTY; SELF ASSEMBLED NANOPARTICLES; SUSTAINED DRUG RELEASE; TARGETED DELIVERY; TARGETED DRUG DELIVERY; TUMOR CELLS;

CELLS; CHEMOTHERAPY; COPOLYMERS; CYTOTOXICITY; DIALYSIS; DRUG DELIVERY; DRUG PRODUCTS; ETHYLENE; GLYCOLS; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; POLYSACCHARIDES;

NANOPARTICLES;

EID: 80053324161     PISSN: 09599428     EISSN: 13645501     Source Type: Journal    
DOI: 10.1039/c1jm11944c     Document Type: Article

References (36)

1. R. K. Jain Delivery of molecular and cellular medicine to solid tumors Adv. Drug Delivery Rev. 2001 46 149 168
2. C. A. Lipinski F. Lombardo B. W. Dominy P. J. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Delivery Rev. 2000 46 3 36
3. G. Y. Lee K. Park S. Y. Kim Y. Byun MMPs-specific PEGylated peptide-DOX conjugate micelles that can contain free doxorubicin Eur. J. Pharm. Biopharm. 2007 67 646 654 (Pubitemid 47576605)
4. K. Kataoka T. Matsumoto M. Yokoyama T. Okano Y. Sakurai S. Fukushima K. Okamoto G. S. Kwon Doxorubicin-loaded poly(ethylene glycol)-poly(β-benzyl- L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance J. Controlled Release 2000 64 143 153 (Pubitemid 30035315)
5. F. M. Muggia Doxorubicin-polymer conjugates: further demonstration of the concept of enhanced permeability and retention Clin. Cancer Res. 1999 5 7 8 (Pubitemid 29045171)
6. F. M. Veronese O. Schiavon G. Pasut R. Mendichi L. Andersson A. Tsirk J. Ford G. Wu S. Kneller J. Davies R. Duncan PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity Bioconjugate Chem. 2005 16 775 784 (Pubitemid 41026163)
7. C. Allen D. Maysinger A. Eisenberg Nano-engineering block copolymer aggregates for drug delivery Colloids Surf., B 1999 16 3 27
8. M. C. Jones J. C. Leroux Polymeric micelles: a new generation of colloidal drug carriers Eur. J. Pharm. Biopharm. 1999 48 101 111
9. V. P. Torchilin Micellar nanocarriers: pharmaceutical perspectives Pharm. Res. 2007 24 1 16 (Pubitemid 44902565)
10. E. S. Lee K. Na Y. H. Bae Polymeric micelle for tumor pH and folate-mediated targeting J. Controlled Release 2003 91 103 113 (Pubitemid 37288881)
11. E. K. Park S. Y. Kim S. B. Lee Y. M. Lee Folate-conjugated methoxy poly(ethylene glycol)/poly(caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery J. Controlled Release 2005 109 158 168 (Pubitemid 41737262)
12. H. S. Yoo T. G. Park Folate receptor targeted biodegradable polymeric doxorubicin micelles J. Controlled Release 2004 96 273 283 (Pubitemid 38481509)
13. H. Maeda T. Sawa T. Konno Mechanism of tumor targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug smancs J. Controlled Release 2001 74 47 61 (Pubitemid 32727608)
14. J. F. Kukowska-Latallo K. A. Candido Z. Y. Cao S. S. Nigavekar I. J. Majoros T. P. Thomas L. P. Balogh M. K. Khan J. R. Baker Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer Cancer Res. 2005 65 5317 5324 (Pubitemid 40827344)
15. R. Duncan Y. N. Sat Tumor targeting by enhanced permeability and retention (EPR) effect Ann. Oncol. 1998 9 39 52
16. H. Maeda J. Wu T. Sawa Y. Matsumura K. Hori Tumor vascular permeability and the epr effect in macromolecular therapeutics: a review J. Controlled Release 2000 65 271 284 (Pubitemid 30122932)
17. A. Agarwal S. Saraf A. Asthana U. Gupta V. Gajbhiye N. K. Jain Ligand based dendritic systems for tumor targeting Int. J. Pharm. 2008 350 3 13
18. F. A. de Wolf G. M. Brett Ligand-binding proteins, their potential for application in systems for controlled delivery and uptake of ligands Pharmacol. Rev. 2000 52 207 236 (Pubitemid 30368432)
19. R. J. Linhardt Heparin: an important drug enters its seventh decade Chem. Ind. 1991 2 45 50
20. R. J. Linhardt 2003 Claude S. Hudson, Award address in carbohydrate chemistry. Heparin: structure and activity J. Med. Chem. 2003 46 2551 2564 (Pubitemid 36702523)
21. S. A. Mousa L. J. Petersen Anti-cancer properties of low-molecular-weight heparin: preclinical evidence Thromb. Haemostasis 2009 102 258 267
22. V. Bobek J. Kovarík Antitumor and antimetastatic effect of warfarin and heparins Biomed. Pharmacother. 2004 58 213 219 (Pubitemid 38746746)
23. T. M. Niers C. P. Klerk M. Dinisio C. J. van Noorden H. R. Büller P. H. Reitsma D. J. Richel Mechanisms of heparin induced anti-cancer activity in experimental cancer models Crit. Rev. Oncol. Hematol. 2007 61 195 207 (Pubitemid 46329424)
24. S. M. Smorenburg C. J. van Noorden The complex effects of heparins on cancer progression and metastasis in experimental studies Pharmacol. Rev. 2001 53 93 105 (Pubitemid 32173109)
25. T. Aoyama M. Horioka S. Nagamitsu Macromolecular complexes of drugs. I. Doxorubicin-heparin complex Chem. Pharm. Bull. 1987 35 808 813 (Pubitemid 17039970)
26. Y. Mizuno T. Hara S. Tachibana K. Uragoh K. Akazawa K. Ueba Doxorubicin-heparin complex: reduction of cardiotoxicity of doxorubicin J. Cancer Res. Clin. Oncol. 1995 121 469 473
27. K. S. Park G. Y. Lee Y. S. Kim M. Yu R. W. Park I. S. Kim S. Y. Kim Y. Byun Heparin-deoxycholic acid chemical conjugate as an anticancer drug carrier and its antitumor activity J. Controlled Release 2006 114 300 306 (Pubitemid 44310810)
28. K. J. Cho H. T. Moon G. Park O. C. Jeon Y. Byun Y. K. Lee Preparation of sodium deoxycholate (DOC) conjugated heparin derivatives for inhibition of angiogenesis and cancer cell growth Bioconjugate Chem. 2008 19 1346 1351 (Pubitemid 352032332)
29. P. E. Thorpe E. J. Derbyshire S. P. Andrade N. Press P. P. Knowles S. King G. J. Watson Y. C. Yang M. R. Bette Heparin-steroid conjugates: new angiogenesis inhibitors with antitumor activity in mice Cancer Res. 1993 53 3000 3007 (Pubitemid 23210303)
30. G. Y. Lee S. K. Kim Y. Byun Glucosylated heparin derivatives as non-toxic anti-cancer drugs J. Controlled Release 2007 123 46 55 (Pubitemid 47449653)
31. L. Li K. M. Huh Y. K. Lee S. Y. Kim Design of multifunctional heparin-based nanoparticle system for anticancer drug delivery Macromol. Res. 2009 18 153 161
32. A. Bisio D. Vecchietti L. Citterio M. Guerrini R. Raman S. Bertini G. Eisele A. Naggi R. Sasisekharan G. Torri Structural features of low-molecular-weight heparins affecting their affinity to antithrombin Thromb. Haemostasis 2009 102 865 873
33. B. Casu I. Vlodavsky R. D. Sanderson Non-anticoagulant heparins and inhibition of cancer Pathophysiol. Haemostasis Thromb. 2008 36 195 203
34. T. Barzu J. L. M. L. van Rijn M. Petitou P. Molho G. Tobelem J. P. Caen Endothelial binding sites for heparin Biochem. J. 1986 238 847 854
35. X. T. Shuai H. Ai N. Nasongkla S. J. Kim J. M. Gao Micellar carriers based on block copolymers of poly(ε-caprolactone) and poly(ethylene glycol) for doxorubicin delivery J. Controlled Release 2004 98 415 426 (Pubitemid 39093952)
36. J. H. Maeng D. H. Lee K. H. Jung Y. H. Bae I. S. Park S. Jeong Y. S. Jeon C. K. Shim W. Y. Kim J. Kim J. M. Lee Y. M. Lee J. H. Kim W. H. Kim S. S. Hong Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer Biomaterials 2010 31 4995 5006